Skip to main content

William Moffitt, Jay Lichter, Dereck Tatman, Murlai Prahalad, Pete De Spain, Istvan Merchenthaler, James Greenwood, Carl Feldbaum, Steve Lombardi


William Moffitt has been named president and chief executive officer of Nanosphere, a Northbrook, Ill.-based developer of a molecular diagnostics platform. Moffitt most recently served as president and CEO of I-Stat, a point-of-care diagnostics manufacturer. The company was purchased by Abbott Laboratories in 2003. Previous to his term at I-Stat, Moffitt held several executive positions at Deerfield, Ill.-based Baxter Healthcare.

Jay Lichter, who was executive vice president of business development at Sequenom, has left the company, an outside company spokesperson confirmed last week. Dereck Tatman and Murlai Prahalad, who serve as directors of business development at Sequenom, have assumed the duties held by Lichter. Also Pete De Spain, manager of corporate communications at Sequenom, has left the company, and is now manager of corporate communications at Anadys Pharmaceuticals, of San Diego.

Istvan Merchenthaler has been appointed chief medical officer at Phylogeny, the company said last week. Merchenthaler will oversee functional genomics studies for Phylogeny’s pharmaceutical and biotech clients, with an emphasis on understanding gene expression patterns in the central nervous system, the company said. Prior to joining Phylogeny, Merchenthaler was employed by Wyeth Research, where he served as a distinguished research scientist and director of functional morphology for the company’s Women’s Health Research Institute for 10 years.

Congressman James Greenwood (R-Pa.) was named the next president of the Biotechnology Industry Organization last week. Greenwood has represented the Eighth District of Pennsylvania in the US House of Representatives since 1993. He previously served in the Pennsylvania House and Senate, and since 2001, he has served as chairman of the Energy and Commerce Subcommittee on Oversight and Investigations. He will be replacing Carl Feldbaum, who has headed BIO since its establishment in July 1993.

Steve Lombardi has been named as a non-executive director of Paris-based molecular diagnostics firm IntegraGen. Lombardi is currently senior vice president of corporate development at Affymetrix.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.